Literature DB >> 16407368

IL-10 deficiency leads to somatic mutations in a model of IBD.

Yuichirou Sato1, Seiichi Takahashi, Yoshitaka Kinouchi, Manabu Shiraki, Katsuya Endo, Yoshifumi Matsumura, Yoichi Kakuta, Masaki Tosa, Atsuhiro Motida, Hiroko Abe, Go Imai, Hiroshi Yokoyama, Eiki Nomura, Kenichi Negoro, Sho Takagi, Hiroyuki Aihara, Ken-ichi Masumura, Takehiko Nohmi, Tooru Shimosegawa.   

Abstract

Individuals with inflammatory bowel disease (IBD) are at increased risk of developing gastrointestinal cancer. Here, we have tested the possibility that chronic inflammation could trigger mutations. For this, we have used IL-10-deficient (IL-10-/-) mice, which spontaneously develop intestinal inflammation, in combination with a transgenic gpt gene and red/gam gene (gpt+IL-10-/-), which is a well-characterized mutation reporter locus. The total mutation frequency in the colon of gpt+IL-10-/- mice was about five times higher than that in normal gpt+IL-10+/+ mice. In the particular case of G:C to A:T transitions, the frequency of mutations in gpt+IL-10-/- mice was 4.1 times higher than that in control mice. Interestingly, the frequency of small deletions and insertions was also strikingly increased (approximately 10 times). The majority of the deletion or insertion mutations were observed in the monotonous base runs or adjacent repeats of short tandem sequences. In contrast, the frequency of large deletions, detected by loss of the Spi marker present in the red/gam transgene, was similar among the mouse strains. Finally, as a control, the mutation frequency in non-inflamed tissues, such as the liver, were similar between gpt+IL-10-/- mice and gpt+IL-10+/+ mice. Our data demonstrate that the chronic inflammatory environment in the colon promotes the generation of mutations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16407368     DOI: 10.1093/carcin/bgi327

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  16 in total

Review 1.  Past, Present and Future Directions of gpt delta Rodent Gene Mutation Assays.

Authors:  Takehiko Nohmi
Journal:  Food Saf (Tokyo)       Date:  2016-03-30

2.  Vaccine against MUC1 antigen expressed in inflammatory bowel disease and cancer lessens colonic inflammation and prevents progression to colitis-associated colon cancer.

Authors:  Pamela L Beatty; Sowmya Narayanan; Jean Gariépy; Sarangarajan Ranganathan; Olivera J Finn
Journal:  Cancer Prev Res (Phila)       Date:  2010-03-23

Review 3.  Animal models for studying epithelial barriers in neonatal necrotizing enterocolitis, inflammatory bowel disease and colorectal cancer.

Authors:  Tiaosi Xing; Rolando Camacho Salazar; Yan-Hua Chen
Journal:  Tissue Barriers       Date:  2017-08-10

4.  Mutagenic potency of Helicobacter pylori in the gastric mucosa of mice is determined by sex and duration of infection.

Authors:  Alexander Sheh; Chung Wei Lee; Kenichi Masumura; Barry H Rickman; Takehiko Nohmi; Gerald N Wogan; James G Fox; David B Schauer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-10       Impact factor: 11.205

5.  Rumex japonicus Houtt. Extract Suppresses Colitis-Associated Colorectal Cancer by Regulating Inflammation and Tight-Junction Integrity in Mice.

Authors:  Hee-Young Kim; Ji Eun Seo; Hanul Lee; Chang-Hwan Bae; Ki-Tae Ha; Seungtae Kim
Journal:  Front Pharmacol       Date:  2022-07-05       Impact factor: 5.988

Review 6.  Chemistry meets biology in colitis-associated carcinogenesis.

Authors:  A Mangerich; P C Dedon; J G Fox; S R Tannenbaum; G N Wogan
Journal:  Free Radic Res       Date:  2013-10-04

7.  Intrinsic mutagenic properties of 5-chlorocytosine: A mechanistic connection between chronic inflammation and cancer.

Authors:  Bogdan I Fedeles; Bret D Freudenthal; Emily Yau; Vipender Singh; Shiou-chi Chang; Deyu Li; James C Delaney; Samuel H Wilson; John M Essigmann
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-04       Impact factor: 11.205

Review 8.  Inflammation-induced DNA damage, mutations and cancer.

Authors:  Jennifer Kay; Elina Thadhani; Leona Samson; Bevin Engelward
Journal:  DNA Repair (Amst)       Date:  2019-07-25

Review 9.  Genetic and biological hallmarks of colorectal cancer.

Authors:  Jiexi Li; Xingdi Ma; Deepavali Chakravarti; Shabnam Shalapour; Ronald A DePinho
Journal:  Genes Dev       Date:  2021-06       Impact factor: 11.361

10.  What can rheumatologists learn from translational cancer therapy?

Authors:  Jonathan P Sherlock; Andrew D Filer; John D Isaacs; Christopher D Buckley
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.